Maxson's trading volume on March 6th was $845 million, a decrease of 38.82% compared to the previous trading day.

On March 6, 2026, the healthcare and nursing product distributor company McKesson (MCK) had a trading value of $845 million, ranking 146th among U.S. stocks on that day. Its trading value decreased by 38.82% from the previous day, and its trading volume on the day was 921.4k.

McKesson (MCK) fell 1.30% on March 6, 2026, to close at $919.26. Over the past 5 trading days, the stock has declined by 6.90%, and it has fallen by 6.90% throughout March. Since the beginning of the year, it is up 12.07%, and over the past 52 weeks, it is up 43.26%.

If the company has been listed for less than 52 weeks, the 52-week gain/loss is calculated as the gain/loss from the listing date to now (the same applies when the listing time is less than 1 month or fewer than 5 trading days).

McKesson released its 2026 fiscal year third-quarter report ( on February 4, 2026, with cumulative ). For the period from April 1, 2025 to December 31, 2025, revenue was $307.135 billion, up 14.51% year over year, and net profit was $3.244 billion, up 49.15% year over year.

McKesson was founded in 1833 and is a global leader in healthcare supply chain management solutions, retail pharmacies, community oncology and specialty care, and healthcare information technology. McKesson works with life sciences companies, manufacturers, suppliers, pharmacies, governments, and other healthcare organizations to help deliver the right medicines, medical products, and healthcare services to the right patients at the right time—safely and in a cost-effective manner.